ABSTRACT. Fluoride pharmacokinetic data are presented for infants given a fluoride supplement. Seventeen infants participated in a total of 20 studies. On one day, 0.013 mmol(0.25 mg) fluoride was given as a supplement (fluoride supplement study), and on another day a placebo was given (control study). Samples of plasma and urine were collected for 5 h and analyzed for fluoride. During control studies fluoride intake averaged 0.15 pmol/kg (2.9 pg/kg), and plasma fluoride concentrations ranged from 0.05 to 0.11 pmol/L (10 to 20 pg/L). In nine instances, the quantity of fluoride excreted in the urine was more than twice that consumed. When the fluoride supplement was given, total fluoride intake averaged 1.93 pmol/kg (36.6 pg/kg). Plasma peak concentration was reached by 30 min in 14 studies and by 60 min in six studies. Mean plasma peak fluoride concentration was 3.3 pmollL (63 ng/mL). Area under the plasma concentration curve averaged 236 nmol. m-' . min (4479 ng . mL-' . min) and was not related to the dose of fluoride. The rate of urinary excretion was significantly correlated with rate of urinary flow. When the dose of fluoride was expressed per unit of body weight, fluoride retention was strongly related to the dose. Retention of the fluoride absorbed from the fluoride dose ranged from 75.4 to 87.6%. Plasma clearance averaged 6.8 mL. kg-'. min-' and decreased significantly with age. Net fractional clearance (renal clearance of the fluoride dose/GFR) averaged 56.770, which was significantly greater than the 29% observed during the control studies. The greater percentage retention of fluoride by infants than by adults is probably explained by a greater capacity of the infant to deposit fluoride in hard tissues. (Pediarr Res 35: 157-163, 1994) On the basis of the belief that an adequate intake of fluoride in early life is protective against caries in later life, fluoride supplements are recommended for infants and children living in areas in which the fluoride content of the drinking water is low. However, critical reviews of the evidence (1-3) have led to the conclusion that the effect of fluoride in decreasing the prevalence and severity of dental caries is not primarily systemic but is exerted locally within the oral cavity (4). Because fluoride supplements are quickly cleared from the mouth, the ~ossibilitv must be considered that they may contribute to enamei fluorosis, which is unquestionably a systemic effect, while providing rela-13). As reviewed by Szpunar and Burt (2) and Fomon and Ekstrand (3), little question exists that regular consumption of fluoride supplements increases the risk of enamel fluorosis. However, the relative importance of fluoride supplements and other sources of fluoride intake is unknown.
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Although metabolic and pharmacokinetic studies of fluoride throughout infancy and childhood are needed. we have focused our attention on studies of infants. Epidemiologic data provide evidence that, at least under some conditions, fluoride intake during infancy may be a causative factor in the development of fluorosis of the permanent teeth (14, 15) . Particularly convincing is the report of Forsman (14) concerning 12-and 13-y-old children who had lived since birth in a Swedish community with 1.2 ppm of fluoride in the drinking water. Dental fluorosis was more common among those who, during the first 4 mo of life, had been fed powdered formulas diluted with the tap water than among those who had been breast-fed (and therefore had consumed very small amounts of fluoride).
Whether fluorosis is predominantly the result of the quantity of fluoride absorbed or is influenced to a major extent by mean or peak plasma fluoride concentrations is unknown. Studies of rats indicate that enamel fluorosis may be associated either with high peak plasma concentrations of fluoride (16, 17) or with sustained and rather moderate plasma concentrations ( 17) . Little is known about the effect of various infant feeding or supplementation regimens on mean or peak plasma fluoride concentrations.
In recently conducted fluoride balance studies with infants (18), we found that fluoride absorption was high (about 90% of intake from formula and about 95% of intake from a fluoride supplement), and that retention of fluoride from a fluoride supplement was approximately 70% of the dose. The study reported here was undertaken to provide data on plasma fluoride profiles and fluoride pharmacokinetics and additional data on fluoride retention by infants given a fluoride supplement. In the pharmacokinetic studies. we determined plasma clearance of fluoride (disappearance rate of fluoride from plasma) and renal and extrarenal clearance of fluoride. Extrarenal clearance of fluoride is the difference between plasma clearance and renal clearance and is an index to the tissue uptake of fluoride. Fractional urinary excretion of fluoride (urinary excretion of fluoride as a fraction of the amount filtered at the glomerulus) was also determined.
MATERIALS AND METHODS tively little protection against dental caries.
Subjects und fieclings. The study protocol was approved by During the last 15 or 20 Y, the dental caries attack rate in the the University of Committee on Research Involving HuUnited States has decreased (5)-a decrease has also been ob-man Subjects, and consent was obtained from one or ~r v e d in a number of other industrialized countries (2). At the both parents. seventeen infants, I girls and 6 boys, participated same time, the prevalence of enamel fluorosis has increased (6- 
' HM. human milk (breast-fed infant): MBF, milk-based formula: ISPF. isolated soy-protein-based formula: CM, cow milk.
had been given for at least several weeks before the study was begun. The concentration of fluoride in human milk (7 ccg/L) was taken from the literature (19) (20) (21) (22) . All other fluoride concentrations were determined (see "Fluoride determinations" section). Study design. Each study was carried out during 2 consecutive days in the Lora N. Thomas Infant Metabolic Unit. On one day. a fluoride supplement was given (fluoride supplement study). and on another day a placebo was given (control study). On the 2 d of study of an infant, procedures were identical except that in most of the control studies fewer blood specimens were obtained.
Procedures. Infants received their early morning feeding at home. After admission to the metabolic unit and at least 2 h after the early morning feeding, the infants were given 50 mL of a 5% glucose solution by bottle. In the fluoride supplement studies, as soon as the baby voided. a precisely weighed amount (approximately 2.5 mL) of a dilute fluoride solution containing 0.01 3 mmol (0.25 mg) of fluoride was given by syringe directly into the infant's mouth and was followed by two rinses of 5 mL of 5% glucose solution. The fluoride solution was prepared by diluting a commercially available fluoride supplement preparation [Pediaflor, Ross Laboratories, Columbus. OH; 0.026 mmol (1.1 mg) sodium fluoride providing 0.026 mmol (0.5 mg) fluoride/l.O mL] 1:5 with 5% glucose solution. In control studies, 2.5 mL of 5% glucose solution was given in similar fashion. followed by two 5-mL rinses of 5% glucose solution. One h after the administration of the fluoride supplement or placebo. the infant was given breast feeding or formula feeding. The intake of fluoride from this feeding is listed in Table 2 for the control studies and is included as a portion of the total fluoride intake for the fluoride supplement studies ( Table 3) . Most of the infants were given a second breast feeding or formula feeding toward the end of the 5-h urinary collection period, but fluoride intake from these feedings probably contributed little to fluoride excretion during the collection period and therefore has not been included as a portion of the fluoride intake.
Before obtaining blood samples, we scrubbed the infant's heel with liquid soap, rinsed it twice with distilled water. then warmed it with a pad soaked in warm water. The skin was swabbed with fluoride-free alcohol, dried, and punctured with a disposable blade (Tenderfoot. International Technidyne Corporation. Edison. NJ). Blood was collected in heparinized tubes free of fluoride. Samples were obtained by heel stick immediately before administration of the placebo solution or the fluoride supplement (time 0). In the fluoride supplement studies. additional blood samples were obtained 30, 60, 120. and 300 min after administration of fluoride. In control studies. blood samples were obtained at these same time points in five studies. In five other studies. only two additional samples were obtained, and in the remaining I0 studies no additional blood samples were obtained. Infants were not fed for at least I h after the fluoride or placebo was given. All individual urine voidings were collected from time 0 to and including the time of collection of the first specimen produced after time 300 min. The weight and pH of each urine sample were determined immediately after the infant voided. and the specimen was stored at -20°C until analyzed for fluoride.
Urine was collected with the infant restrained on a metabolic bed as described Fomon rt ul. (23) and subsequently modified (24) with respect to collection from female infants. During the period of urine collection, the infant remained under direct observation of a research nurse in the Lora N. Thomas Pediatric Metabolic Unit. Urine volume and pH were measured within minutes after the voiding, and samples were labeled and stored in a refrigerator until completion of the study.
Fluoridc~ dc.rerminutions. The fluoride concentration of infant formulas was determined in triplicate by a minor modification of the microdiffusion technique originally described by Taves (25) . One g of the sample was diffused for 6 h at room temperature in sealed plastic Petri dishes with 2 mL of 4 N HClO., saturated with hexamethyldisiloxane. and the lids were prepared with 50 ccL of 0.5 N NaOH. After the sample was diffused, the lids were dried in a dessicator. The dried layer was dissolved with 50 pL of 0.5 N HC1 and 100 gL of 0.25 M acetate buffer. pH 5.0. Fluoride concentration was measured with a fluoride ion specific electrode (Orion, model 9609. Waltham, MA). The fluoride ion specific electrode was also used for determining fluoride concentration of plasma and urine. To adjust ionic strength and pH, we added one-tenth volume of fluoride-free 7.5 M acetate buffer, pH 5.0, containing 2% CDTA (trans-1.2-diaminocyclohexane-N,N.N1.N' tetraacetic acid) to fluoride standards and samples. In the anticipated concentration range, the relative SD of direct fluoride measurement in plasma has been shown to be less than 5% (26). -----* DF, dose of fluonde supplement. T,,,, tlme at whlch peak plasma fluonde concentratlon was observed, Pt,,,, the peak plasma fluonde concentratlon, AUCF.,,, the area under the plasma fluor~de concentratlon curve attnbutable to the fluonde dose
Creatinine in urine was determined with a Gilford chemical of urine flow ( V ) for each interval from one urination to the analyzer (model SBA 300, Ciba Coming Diagnostics, Oberlin, next, beginning with time 0. The quantity of fluoride excreted in OH) using a modification of the Jaffe method as described in the interval was determined by multiplying the rate of urinary the Gilford manual of procedures.
excretion of fluoride by the elapsed time. The rate of urinary Pharmacokinetic culculations. In the control studies, the rate excretion for the approximately 5-h period was determined as of urinary excretion of fluoride (UF . V) was determined by the sum of the fluoride excretion in the several intervals divided multiplying fluoride concentration of the urine (UF) by the rate by the total elapsed time of collection, and was adjusted for body 160 EKSTRAND ET . 4~ weight ( n g kg-'. min-') and designated (UF . V),. Urinary excretion of fluoride in 5 h was calculated by multiplying the rate of excretion per minute by 300 min. The adjusted rate of urinary flow for the 300-min period was designated V,.
For each infant, urinary excretion attributable to the supplement, (UF . V)t,nc,, was calculated as (UF . V), observed in the fluoride supplement study minus (UF . V), in the control study. Statistical analysis. The data were summarized using standard descriptive statistics and linear regression with SAS version 5.18 (SAS Institute, Cary, NC).
RESULTS
Control studies. Fluoride intake from a single feeding of milk or infant formula averaged 0.15 pmol/kg (2.9 pg/kg) ( Table 2 ). The single feeding intake by breast-fed infants was 5.3 nmol/kg (0.1 pg/kg); for infants fed cow milk or a milk-based formula with fluoride concentration of 2.9 to 10.9 pmol/L (55 to 208 pg/ L), intakes ranged from 36.8 to 136.8 nmol/kg (0.7 to 2.6 pg/ kg); and for those fed an isolated soy protein-based formula with fluoride concentration 308 &L, intakes ranged from 0.22 to 0.55 pmollkg (4.1 to 10.5 pg/kg). Plasma fluoride concentrations ranged from 0.53 to 1.05 nmol/kg (I0 to 20 ng/mL) and were not correlated with fluoride concentration of the feeding.
Urinary excretion during the 5-h collection period averaged 0.45 nmol . kg-'. min-I (8.5 ng. kg-' . min-I). ranging from 0.23 to 0.82 nmol. kg-'. min-I (4.4 to 15.5 ng. kg-'. min-I). With the exception of the infants fed isolated soy protein-based formulas. urinary excretion generally exceeded the single feeding intake.
The finding that urinary excretion sometimes exceeded intake cannot be explained primarily by the excretion of fluoride from a second feeding given near the end of the 5-h study period. In nine instances, the quantity of fluoride excreted in the urine was more than twice that of the single feeding intake, and urinary excretion of fluoride by the breast-fed infants exceeded intake many fold. For the entire 20 studies, the slope of the regression of 5-h urinary excretion of fluoride on intake was not significantly different from zero ( r = -0.353, p = 0.127). Urinary pH ranged from 5.36 to 7.42: the rate of urinary excretion of fluoride was not correlated with urinary pH ( r = -0.258: p = 0.272). Assuming 90% absorption of fluoride from formula (18) or milk, the mean quantity of absorbed fluoride was 0.14 mmol/kg (2.65 &kg). Retention of fluoride was 5.3 nmol/kg (0.10 pg/ kg), or 3.5% of the quantity absorbed. Retention of fluoride during the 5-h study period was strongly correlated to intake of fluoride (Fig. I , r = 0.956, p < 0.00 1 ).
GFR averaged 1.95 mL. kg-'. min-' (Table 2 ). Renal clearance of fluoride (mean, 0.57 mL. kg-l.min-') was not related to urinary pH or to rate of urine flow (mL. kg-'. min-I). Fractional renal clearance of fluoride averaged 29% and did not increase with increasing age.
Fllroridr .slrpplement studies. Data from the fluoride supplement studies are summarized in Tables 3 and 4 and Figure 2 . The mean quantity of fluoride provided by the supplement was 1.75 pmol/kg (33.2 pglkg), and the mean total fluoride intake (intake from supplement plus single feeding) was 1.93 pmol/kg (36.6 pg/kg) ( Table 3 ). Plasma fluoride concentration increased after administration of the fluoride supplement (Fig. 2) . Peak plasma concentration was reached by 30 min in 14 studies and by 60 min in six studies (Table 3) . and in no instance was the concentration in plasma greater at 120 min than at 60 min. The average peak fluoride concentration (PF.max) was 3. -0.633. 11 < 0.003) with age and was negatively correlatcd ~i t h body weight (r. = -0.6 15. 11 = 0.04).
Extrarenal clearance of the fluoridc dose (CERI ,,.,) a~craged 5.7 mL.kg-l.rnin-' and decreased significantly with age ( r = -0,673. 11 = 0.001) and body size ( r = 0.725. 11 < 0.001).
Extrarenal clearance of the dose accounted for 83.4"; of total plasma clearance of the dose. Because extrarcnal clearance of the fluoridc dose divided by plasma clearance of the fluoride dose represents retention. this value is the same as the u l u e for net retcntion of fluoride as a percent of absorbed fluoridc tiom the tluoride dose (Retl , , , , . 100/0.95 . D l . Table 4 ). absorbed (Ret,.,,, . 100/0.95 . Dl ) varied from 75.4 to 87.6"; of the dose, with a mean of 83.400 (Table 4) .
Plasma clearance of the fluoride dose (CP,,,.,) averaged 6.8 m L . kg-' .min-' (Table 4 ) and decreased significantly with age ( r = -0.685. p < 0.001) and with body weight ( r = -0.702. 17 < 0.001). However. the study was not designed to explore the effects of age or body size on plasma clearance. and further study of these relationships will be necessary.
Renal clearance of the fluoride dose. CRI . , , , (mean. I. I mL.
kg-'. min-I), also decreased significantly with age ( r = -0.603.p = 0.005) and was inversely correlated with body weight ( r = -0.543. p = 0.013). G F R (data not shown) averaged 1.96 m L .
kg-' .min-', a value similar to that observed in the control studies (Table 2 ). Net fractional renal clearance (CRI.,,, . IOO/GFK) averaged 56.7% (Table 4) . a value significantly greater (paired t test, p < 0.00 I ) than the 29% observed during the control studies.
Net fractional renal clearance decreased significantly ( r = Although plasma concentrations of fluoride, renal clcarance of fluoride, and fluoride pharmacokinetics have been extensively studied in human adults (27) (28) (29) (30) (31) (32) (33) and renal clearance of fluoride has been studied in children and adolescents (34) . the data reported here arc the first concerning infants. Data on 5-h retention of fluoride are also presented and are compared with our previously presented data on fluoridc retention ( 18) obtained with 72-h metabolic balance studies.
When intakes of fluoride derived tiom human milk. infant formula. or cow milk were 0.14 p m o l . k g ' . d ' (2.6 pg.kg-'. d -' ) or less. urinary excretion of fluoride generally exceeded intake and in some instances by a considerable margin. Earlier studies of infants receiving low intakes of fluoride from human milk also demonstrated negative fluoride balances (22.35) . When intakes of fluoride were 0.22 to 0.55 pmol. k g ' . d-' (4.1 to 10.5 pg. k g 1 . d l ) . intakes exceeded urinar! excretion. but the rate of urinary excretion was not greater than observed at the low intakes. Thus. the data suggest that when tluoride intakes are extremely low, suflicient fluoride is released liom bone to extracellular fluid to result in urinary excretion of fluoride at least as great as that observed when intakes of fluoride are at a somewhat higher level.
In the tluoride supplement studies. intakes of fluoridc from a EKSTRAND E7' ..I/.. single feeding plus the supplement ranged from 2 1.6 to 67.4 pg/ kg. The strongly positive correlation between urinary excretion of fluoride and fluoride intake during the fluoride supplement studies was in sharp contrast to the lack of correlation in the control studies. Both in the control studies and in the fluoride supplement studies, fluoride retention was strongly correlated with fluoride intake (Fig. 1) .
In the control studies, mean plasma fluoride concentrations did not reflect intake, and significant increases above the baseline plasma fluoride concentration were not observed after feeding. Fractional renal clearance of fluoride in our control studies averaged 29% (Table 2 ). a value intermediate between the values of 20% and 34% reported by Schim and Binswanger (3 1 , 32) in two studies of adult subjects but less than the 40% reported by Spak el al. (34) for children and adolescents from 4 to 18 y of age. Considerably greater values were observed in a study of two normal adults (33) . In all of these studies, GFR was determined with the inulin clearance method, whereas we used the creatinine clearance method. In the study by Jarnberg cJt a/. (33) . fractional clearance of fluoride was not remarkably different in control (mean, 75% in eight periods of observation) and fluoride supplement studies (mean. 79% in 12 periods). In our fluoride supplement studies, fractional renal clearance of fluoride (56.8% of intake) was significantly greater than in control studies. We have no explanation for this difference.
In our fluoride supplement studies, the infrequency of blood sampling made it impossible to determine the time at which the peak plasma concentration of fluoride was reached. Nevertheless. in at least some of the infants, peak plasma concentration had not been reached by 30 min after administration of the supplement. By contrast, in studies of adults (28) , peak plasma concentration was regularly achieved by 30 min after administration of the supplement. The longer time required to reach peak plasma concentration by the infants than by the adults may merely reflect the longer period of fasting by the adult subjects (12 h before and 3 h after the time of administration of the supplement).
Neither the peak plasma concentration of fluoride nor the area under the plasma fluoride concentration curve attributable to the fluoride dose was correlated with fluoride intake. Failure to demonstrate these correlations is probably explained by the relatively small range of fluoride intakes and the considerable individual variability. When adult subjects were given widely differing doses of fluoride ranging from approximately 0.12 to 0.52 mmol(3 to 10 mg). the area under the plasma concentration curve in a specified subject was greater when the fluoride dose was greater, but between subjects at the same fluoride intake. there was considerable variability in the area under the plasma concentration curve (27, 28) .
A significant correlation between renal clearance of fluoride and urinary pH has been demonstrated in studies of adult subjects (29, 30, 33) . Presumably, reabsorption of fluoride from the renal tubules occurs predominantly by diffusion of nonionic hydrogen fluoride, and the lower the urinary pH the greater the percentage of fluoride in the form of hydrogen fluoride (29) . Our failure to find a correlation between renal clearance of fluoride and urinary pH may be because our study. in contrast to the studies of adults, was not designed to explore this relationship. and other variables may have obscured the effect of urinary pH.
In the fluoride supplement studies but not in the control studies. we found a significant correlation between renal clearance of fluoride and rate of urinary flow. a relationship that has been observed in adult subjects under some (27. 29. 30. 32-34) but not all (30) conditions. Both in the control studies and in the fluoride supplement studies, retention of fluoride was strongly correlated with fluoride intake (Fig. I) . Retention of fluoride from the fluoride supplement was 79% of intake. This value is not remarkably different from the 73% of intake determined in other infants by 72-h balance studies (18) in which the dose of fluoride supplement was given in a similar temporal relationship to feeding.
Retention of fluoride from the dose of supplement. when expressed as percentage of the quantity of fluoride absorbed from the dose, is the same as extrarenal clearance of the fluoride dose expressed as a percentage of plasma clearance of the dose. Our finding that mean retention of fluoride was 83.4% of the quantity of fluoride absorbed from the dose of supplement (Table 3 ) may be compared with the finding in adults that mean extrarenal clearance of fluoride from a dose of supplement given to adults was 55.3% of plasma clearance of the dose (29) . The difference is statistically significant ( I test. p = <0.001). Similarly. the value in infants for retention of fluoride expressed as percentage of absorbed fluoride (83.4%) can be compared with results of a study of normal adults in which 3 mg of fluoride (about 45 pg/ kg) was infused intravenously over a period of 30 min (27) . Urinary excretion during the next 34 h averaged 42% of intake. indicating that retention of fluoride was 58% of the quantity infused. The greater percentage retention of absorbed fluoride by infants than by the adults is probably explained primarily by a greater capacity of the infant to deposit fluoride in hard tissues (36) .
